Development of a Metabolic Assessment Tool for Chronic Kidney Disease

Completed · Not applicable

Conditions studied: Immunoglobulin A Nephropathy, Healthy Subjects

In brief

The purpose of this study is to examine the variation between individuals in blood lipid metabolites, and the changes in these metabolites in response to omega-3 fatty acids in patients with immunoglobulin A nephropathy (IgAN) and in healthy subjects. The hypothesis is that measuring variation among individuals and changes in response to omega-3 fatty acids comprehensively by using metabolomics will help to identify those individuals who are responders and those who are non-responders to omega-3 fatty acids as an anti-inflammatory intervention.

Key facts

Study ID
NCT01838239
Run by
University of California, Davis
People needed
12
Starts
2008-06-01
Expected to finish
2011-06-01
Last updated by the study team
2017-05-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.